Our study shows that aPKCλ/ι is predominantly expressed and activated in human CML and B-ALL progenitors as well as in BCR-ABL+ murine LSC/P. This evidence concerns the gene ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive.